CelluJuve® for the Treatment of Moderate to Severe NLFs

Part of paid clinical trials in Coral Gables, Florida.

Sponsor: Spiderwort Biotechnologies Inc.
Study ID: NCT07545980
Status: Recruiting

Apply to this trial

Conditions

Nasolabial Fold Wrinkles

Eligibility Criteria

Sex: ALL
Age: 22 Years - N/A
Healthy Volunteers: Not accepted

Interventions

CelluJuve® — DEVICE
CelluJuve®

Study Details

Single-center, open-label proof of concept study assessing the safety and effectiveness of CelluJuve® for the treatment of moderate to severe NLFs

Key Dates

Start date: Apr 29, 2026
Status verified: Apr 2026
Primary completion: Oct 15, 2026
Completion: Jul 31, 2028

Study Design

Enrollment: 12 participants (estimated)
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Arms

Experimental: CelluJuve®
CelluJuve® injected into left and right NLF

Primary Outcome Measure

Wrinkle Severity Rating Scale [ Time Frame: 2 months, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months, 24 months ]

Central Contacts

Serpil Kucuktepe, PhD
1-866-384-4221
[email protected]

Locations (1)

Facility	City	State	ZIP	Site coordinators
Skin Research Institute LLC	Coral Gables	Florida	33146	-

Find similar trials in Coral Gables, FL

By research site

Skin Research Institute LLC· Coral Gables, FL